Board of Directors

On average, our board members have 20 years of industry experience.

They leverage their shared business, operational and clinical knowledge to help our members develop thriving solutions for today’s dynamic healthcare sector.


Founding Partner, Patient Square Capital - Chairperson

Alex Albert

Partner, The Vistria Group - Vice Chairperson

Amy Christensen

Ms Christensen is a Partner and Co-Head of Healthcare at The Vistria Group.  Prior to joining Vistria, Ms. Christensen was a Vice President at NewSpring Capital, a middle market private equity firm with a family of funds, including a dedicated healthcare fund. Prior to NewSpring, Ms. Christensen was an investment professional with the Gores Group and Calder Capital Partners. Ms. Christensen began her career as a healthcare consultant with the Huron Consulting Group.

Ms. Christensen currently serves on the Board of Directors of Behavioral Health Group, Chiro One, Supplemental Healthcare, Beacon Specialized Living, and Sandstone Care.  She previously served on the boards of St. Croix Hospice, Angel Medflight, and Alacura.

Ms. Christensen received a B.S. from Northwestern University summa cum laude and an M.B.A. from The University of Chicago Booth School of Business where she was an Andrew Alper Merit Scholar.


TJ Carella
Managing Director, Warburg Pincus - Director

Thomas (T.J.) Carella

 Thomas “TJ” Carella joined Warburg Pincus in 2016. Based in New York, he serves as a Managing Director and is Head of the Healthcare Group. He is a Director of Aetion, Alignment Healthcare, Polyplus Transfection, Quantum Health, SOC Telemed, Summit Health, Vertice Pharma and WebPT. Prior to joining Warburg Pincus, TJ was a Partner in the Merchant Banking Division of Goldman Sachs and Global Head of the division’s Private Equity activities in the Healthcare sector. While at Goldman Sachs, he led, or was actively involved in several investments across Life Sciences, Healthcare Services and Healthcare Information Technology. He earned his bachelor’s degree from Harvard College and his M.B.A. from Harvard Business School. 
Managing Director, TA Associates - Director

Mark Carter

Partner, Apax Partners - Director

Andrew Cavanna

Andrew Cavanna is a Partner and Co-Head of Healthcare at Apax Partners. He joined Apax in 2017 and is based in New York. Andrew serves on the board of Eating Recovery Center (ERC), Kepro and InnovAge and previously served on the board of Genex. Andrew is also a Member of the Cornell College of Arts and Sciences Advisory Council and Board Member of School in the Square, a charter school providing elementary and middle school education to the Washington Heights community in New York City.

Prior to joining Apax, Andrew spent eleven years at Vestar Capital Partners where he was a Managing Director and Co-Head of the Healthcare Sector. At Vestar, Andrew was involved with a number of investments including Press Ganey, Essent Healthcare, StayWell, Joerns Healthcare, Sunrise Medical, Institutional Shareholder Services (ISS) and Veritas Collaborative. Andrew came to Vestar in 2006 from The Blackstone Group. Prior to Blackstone, Andrew was a Senior Associate at JPMorgan Partners. Andrew started his career as an Analyst in Leveraged Finance at Merrill Lynch.

Andrew holds an MBA from Columbia Business School and a BA, cum laude, in Economics and Government from Cornell University.

Managing Director, Nautic Partners - Director

Christopher Crosby

Mr. Crosby joined Nautic Partners in 2001.  Mr. Crosby focuses on healthcare investments and currently serves on the Boards of Directors of Mikart Holdings, Integrated Homecare Services, Nystrom Associates and Pyramid Healthcare. Mr. Crosby is also a member of Nautic’s Investment and Executive Committees.

Mr. Crosby received a BA from Boston College and an MBA from the Harvard Business School.  Mr. Crosby is a board member of Blue Cross Blue Shield of RI where he is on the Compensation and Finance Committees.

Partner, Harvest Partners - Director

Paige Daly

Paige Daly is a Partner at Harvest Partners which she joined in 2010. She concentrates on growth capital, buyout, and recapitalization investments in healthcare and consumer businesses. Prior to joining Harvest, Ms. Daly was a Partner at Apax Partners.

Ms. Daly has a BS in Economics from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School. She currently serves on the boards of Advance Dermatology and Dental Care Alliance.

Partner, CVC Capital Partners - Director

Fazle Husain

Fazle Husain is Head of US Healthcare at CVC Capital Partners, a global private equity firm with a network of 23 offices and over 400 employees throughout Europe, Asia and US. The CVC Group manages over $50 billion of assets. Prior to joining CVC Capital, Fazle was a Managing Director at Metalmark Capital from 2007-2016, and was responsible for leading their effort in healthcare. Before Metalmark Capital, he was with Morgan Stanley & Co. in the private equity business, where he spent 18 years. He has a successful track record of investing in healthcare companies for over 25 years, including investments in the healthcare service, medical device, specialty pharmaceuticals and healthcare information technology sectors. He has invested in and served on the Boards of several private and public companies including ExamWorks, MedRisk, Icario, Allscripts (MDRX), Cross Country Healthcare (CCRN), The Medicines Company (MDCO), Cardiac Pathways (sold to Boston Scientific), Suros Surgical (sold to Hologic), Healthstream (HSTM), Cytyc Corp (sold to Hologic), Aegis Sciences, and Vanguard Healthcare Systems (sold to Tenet). He was the Chairman of the Board of Healogics (2008-2014), and was the Chairman of the Board of Collagen Matrix (2014-2016).

Mr. Husain received an Sc.B. degree in Chemical Engineering from Brown University, and an M.B.A. from Harvard Business School. He is on the Board of Advisors for The School of Engineering at Brown University. He lives in New York City, with his wife and three children.

Partner, Two Sigma - Director

Geoff Lieberthal

Geoff is a Partner of Two Sigma Impact, the private equity business of Two Sigma. Prior to Two Sigma, Geoff worked in the private equity funds of Lee Equity Partners, TPG Capital and Bain Capital and began his career as a consultant at Bain & Company. Geoff has been a director of several companies, including Circle of Care, Solaris Health, Summit BHC, Westfall Technik, Eating Recovery Centers, PDR Networks, Key Health, Paragon Industries, and Aptalis Pharma. Geoff was a faculty lecturer at Stanford Business School and is a member of the Board of Directors of the Healthcare Private Equity Association. Geoff is also a co-founder of Inspire Inc, a volunteer consulting non-profit organization, where he continues to serve as a director. Geoff received an M.B.A. from Stanford Business School and a B.A. in Engineering Sciences cum laude from Dartmouth College.
Ben Magnano
Managing Partner, Frazier Healthcare Partners - Director

Ben Magnano

Ben joined Frazier Healthcare Partners in 2006. He represents Frazier on the boards of CSafe Global, Caravel Autism Health, Comprehensive Pharmacy Services, Matrix Medical Network, Parata Systems, SunMed and United Derm Partners. Ben has been responsible for Frazier’s successful investments in Ascension Orthopedics, DSI Renal, Golden State Medical Supply, Laboratory Supply Company and Northfield Medical.

Prior to Frazier, Ben was at Morgan Stanley Capital Partners (MSCP), focusing on investing in the healthcare sector. Before joining MSCP, he was in the Healthcare Investment Banking Group of Morgan Stanley.

Ben is also an Advisor for American Corporate Partners, a nationwide mentoring program dedicated to helping veterans transition to the private sector.

Ben received his M.B.A from the Tuck School of Business at Dartmouth and his B.B.A. in Finance and Computer Applications from the University of Notre Dame.

Managing Partner, Advent International - Director

John Maldonado

John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital.  During his career, John has worked on 24 investments, 19 during his time at Advent, including AccentCare, Bharat Serums and Vaccines, Cotiviti, Definitive Healthcare, Genoa Healthcare, RA Chem Pharma Limited and RxBenefits.

John began his career as a Consultant with The Parthenon Group, a leading strategy consulting firm. He earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School.

General Partner, Welsh, Carson, Anderson & Stowe - Director

Nicholas O'Leary

Mr. O’Leary is a General Partner, having joined WCAS in 2015. Prior to joining WCAS, Mr. O’Leary worked at JLL Partners for over six years, focused primarily on healthcare investments. Earlier in his career, he worked in the Mergers and Acquisitions group at Merrill Lynch.

Mr. O’Leary received a B.A. from Washington and Lee University.

Partner, CD&R - Director

Ravi Sachdev

Mr. Sachdev joined CD&R in 2015. He played a key role in the Firm’s investments in agilon health, naviHealth, TRANZACT, and Covetrus. Previously, he served as a managing director and co-head of healthcare services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A, and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant, and the IPOs of HealthEquity, SCA, Premier, and IMS Health. He serves on the board of the Healthcare Private Equity Association. Mr. Sachdev has a B.A. in economics from the University of Michigan.


CD&R Investments

Doug Schillinger
Managing Director, DW Healthcare Partners - Director

Doug Schillinger

Doug is a Managing Director with DW Healthcare Partners. His investment and transaction experience includes bio-analytical/immune-analytical service laboratories, institutional and specialty pharmacies, medical device manufacturers in the cardiac and orthopedic markets, physician practice management companies, elder care service providers and clinical research organizations.

Before joining DW Healthcare Partners, Doug worked for Bain & Company. While there, Doug led strategic due diligence efforts as part of Bain’s Private Equity Group. Prior to joining Bain’s Private Equity Group, Doug advised Bain’s commercial clients in the consumer products and food service industries.

Doug received a Bachelors degree from Cornell University and an MBA with Distinction from Harvard Business School, and previously sat on the Harvard Business School Alumni Board of Directors.

Managing Director, Blackstone - Director

Anushka Sunder

Anushka Sunder is a Managing Director in Blackstone’s Private Equity Group. Ms. Sunder focuses primarily on Blackstone’s private equity investments in healthcare and technology. Ms. Sunder serves on the Board of Directors of Blue Yonder, CARD, HealthEdge, Optiv, Precision Medicine Group, and TeamHealth and has also been actively involved in the execution of Blackstone’s investments in InComm, NCR, Outerstuff, and Signature Aviation. She is co-chair of the Blackstone Women’s Initiative task force and on the Blackstone Charitable Foundation Leadership Council.  Before joining Blackstone in 2013, Ms. Sunder was an associate at TPG Capital and an analyst at Goldman Sachs in the Financial Institutions Group. Ms. Sunder received an AB in Economics from Harvard College, where she graduated magna cum laude and Phi Beta Kappa, and an MBA from Harvard Business School. She is also a member of the Corporate Leaders Program at the Council on Foreign Relations.

Past Board Chairs

Brian Miller
Founder, HCPEA; Managing Partner & Co-Founder, Linden Capital Partners

Brian Miller

Brian Miller is a Managing Partner and Co-Founder of Linden Capital Partners, a Chicago-based healthcare and life sciences private equity fund.

He has been focused on healthcare private equity since 1998 when he was a founding member of the healthcare team at First Chicago Equity Capital (currently JP Morgan). Mr. Miller began his career in the investment banking division of Salomon Brothers, Inc. (currently Citigroup). He has served on a number of boards: BarrierSafe Solutions International, CORPAK Medsystems, HYCOR BioMedical, SeraCare, Life Sciences Strata Pathology, and Suture Express.

Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School with a concentration in healthcare. He is a Board Member of AdvaMedDx, the founder of Private Equity Analysts of Chicago, a Trustee of the Latin School of Chicago, and a member of the Economic Club of Chicago.

Michael Dal Ballo
Investment Partner, Pritzker Private Capital

Michael Dal Ballo

Michael is an Investment Partner at Pritzker Private Capital (“PPC”) leading the firm’s Healthcare sector investing.  At PPC Michael has overseen investments in Clinical Innovations, PathGroup and KabaFusion.  Prior to joining Pritzker Private Capital, Michael was a Managing Director at Blackstone Capital Partners, a multi-billion dollar private equity enterprise. During his tenure at Blackstone, Michael helped lead sourcing efforts in healthcare and insurance, investing billions of equity capital in 13 transactions. Michael also served on ten corporate boards, working with management teams to drive value through operational improvements, acquisitions and divestitures. Before joining Blackstone, Michael was an Associate at Hellman & Friedman where he was involved with the analysis and execution of private equity investments in the media and professional services sectors. Prior to that, Michael worked as a consultant at Bain & Company and also was a Research Associate at the China Center for Economic Research in Beijing, PR China as a Luce Scholar.

Michael earned an MBA from Harvard Business School, an MA from Oxford University where he was a Thouron Scholar and undergraduate degrees from the Wharton School and the College of Arts and Sciences at the University of Pennsylvania. He is a member of the Council on Foreign Relations.

Diane Daych
Managing Partner and Co-Founder, Granite Growth Health Partners

Diane Daych

Diane Daych is a Managing Partner and Co-Founder at Granite Growth Health Partners. She has more than 30 years of investing, advisory and operating experience, with more than 25 years of experience in the health services industry investing in growth companies that offer specialized solutions for the financing, management and delivery of healthcare. Before founding Granite Growth, Diane led Apple Tree Partners’ healthcare services investing team. From 2010 to 2012, she was a managing director and co-head, Private Equity, of the Marwood Group. Previously, since 2000 she was a partner and principal at CCP Equity Partners.  Diane currently sits on the Board of Directors of CleanSlate Outpatient Addiction Medicine, QualDerm Partners, Three Oaks Hospice, the National Venture Capital Association, the Tuck Center for Private Equity and Venture Capital and is a past Chair of the Healthcare Private Equity Association.

Diane earned an MBA from the Tuck School at Dartmouth College and a BA in Economics from Lehigh University.

Managing Director, Global Head and Founder of healthcare private equity at Ontario Teachers’

Terry Woodward

Terry Woodward is a Managing Director and global head and founder of the healthcare private equity at Ontario Teachers’ (OTPP). Terry served on the board of HCPEA for over 6 years and was Chair from 2018 to 2020.

Prior to leading healthcare private equity, Terry led global venture capital and growth equity at OTPP. OTPP has a global portfolio in healthcare private equity, leading deals in North America, Europe and Asia.  Terry and the healthcare team led/co-led investments including:  Inc Research, Amica Senior Lifestyles, Heartland Dental, Asia Pacific Healthcare Group, Phynet Dermatology, PetVet Care Centers, Acorn Health, Nvision Eye Centers, and Abano Healthcare. Terry has a Ph.D. from McGill University and an MBA from Michigan State.

Managing Director, Summit Partners

Craig Frances

Craig joined Summit Partners in 2003 and focuses primarily on the healthcare & life sciences sector.

Craig’s board directorships and investments include HealthCare Partners (merged with DaVita, NYSE: DVA), Integrated DNA Technologies (acquired by Danaher), Healthline Media (acquired by Red Ventures), National Veterinary Associates (acquired by Ares Management), BluePearl Veterinary Services (acquired by Mars Petcare), Independent Vetcare (acquired by EQT), MedSpring Urgent Care (acquired by Fresenius Medical Care), Physicians Formula (NASDAQ: FACE) and Solutionreach.

Prior to Summit, Craig was founder and manager of three successful companies. He was also the Chief Medical Resident at the University of California, San Francisco. Craig holds a BA in psychology, with honors, from Cornell University and an MD from Cornell University Medical College, where he was valedictorian and received the Paul Sherlock Prize, a peer-voted award for exceptional integrity and compassion in patient care. He is the creator of the Saint-Frances Series, medical books that are used extensively in academic centers across the United States.

Craig has numerous publications in leading journals, including the New England Journal of Medicine, and has collaborated with many national healthcare leaders. He serves as an advisor to the Cornell University Trustees Investment Committee regarding private equity, and he is a former President of the Healthcare Private Equity Association (HCPEA). Craig has been named one of the 40 Smartest People in Healthcare by Becker’s Hospital Review.

Managing Director, Regal Healthcare Capital Partners

Joseph Ibrahim

Joseph is a Managing Director at Regal Healthcare Capital Partners. Joseph joins Regal with fifteen years of successful middle market healthcare private equity experience, including responsibilities in deal sourcing, oversight of deal execution and portfolio management. Prior to Regal, Joseph was a Managing Partner with MBF Healthcare Partners and focused primarily on investments in multi-site healthcare services buy and build strategies. Prior to MBF, Joseph worked at The Riverside Company and was responsible for the evaluation of healthcare acquisitions in North America, Europe, and the Asia-Pacific region. Mr. Ibrahim received a B.A. from Vanderbilt University and MBA from Wake Forest University – Babock Graduate School of Management.